| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_935c9e505474c2cfb2373f8844239f62 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-82 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5041 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/H01L27-146 |
| filingDate |
2012-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42fcfd21906b54a669b4a485d91f6051 |
| publicationDate |
2013-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2013071099-A1 |
| titleOfInvention |
A drug screening method and uses thereof |
| abstract |
Described herein are methods of screening drugs in a non-human animal using high resolution technology leading to generation of pharmacomaps. Further described herein are methods of predicting the therapeutic benefit and/or toxicity of drug candidate compounds. In specific embodiments, provided herein are methods of predicting the clinical effects of a test drug based on comparison of the pharmacomap of the test drug to the pharmacomap of one or more reference drugs with known clinical outcomes. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021030270-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11676684-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102344774-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023044336-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111657861-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10603390-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20160037950-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015017449-A1 |
| priorityDate |
2011-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |